|
Market Closed -
BME
16:38:40 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 59.30 EUR | -0.42% |
|
-2.55% | -6.61% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.42% | -2.55% | +1.19% | +0.85% | -6.61% | -0.59% | +16.50% | +2.07% | +338.93% | 3.52B | |
| -0.88% | -2.15% | -3.57% | +1.59% | +6.95% | +58.05% | +105.26% | +342.86% | +1,363.97% | 1,024B | |
| -1.15% | +2.68% | +7.10% | +18.24% | +32.99% | +54.25% | +74.19% | +57.24% | +129.84% | 663B | |
| -1.44% | +0.38% | +5.16% | +12.86% | +12.24% | +20.65% | +76.13% | +129.76% | +296.94% | 453B | |
| +0.14% | -0.47% | -2.11% | +9.14% | +8.78% | +30.20% | +41.44% | -2.88% | +46.55% | 352B | |
| -1.33% | +4.72% | +3.51% | +9.83% | +18.23% | +24.62% | +48.58% | +54.94% | +66.34% | 304B | |
| -1.15% | +0.30% | +1.32% | -13.36% | -12.94% | -0.69% | +13.20% | +38.88% | +146.73% | 252B | |
| -1.55% | +1.11% | +8.00% | +25.07% | +33.58% | +54.15% | +75.59% | +93.15% | +155.93% | 236B | |
| -0.88% | +1.15% | +1.81% | +5.30% | -8.10% | -14.60% | -54.96% | -6.15% | +97.36% | 206B | |
| -0.15% | +3.65% | +15.39% | +16.91% | +23.02% | +31.24% | +103.39% | +109.83% | +93.88% | 187B | |
| -1.25% | +1.75% | +8.59% | +9.25% | +14.26% | +14.35% | -17.22% | -39.26% | -18.18% | 162B | |
| -2.12% | +0.82% | +12.83% | +22.22% | +20.46% | +37.87% | +58.61% | +175.75% | +470.18% | 138B | |
| -1.87% | +0.36% | +4.16% | +16.68% | +23.88% | +41.75% | +11.98% | +1.84% | +17.31% | 136B | |
| -0.01% | -1.28% | +2.62% | -2.17% | -7.81% | -4.08% | -22.37% | -13.14% | +8.82% | 106B | |
| -1.07% | -0.38% | -4.65% | -4.72% | +1.21% | +25.10% | +34.13% | -0.74% | -9.46% | 100B | |
| -2.19% | -3.86% | -3.08% | -10.97% | -19.37% | -0.48% | +48.98% | +50.74% | +484.69% | 71.64B | |
| +0.17% | -0.05% | +4.01% | +14.10% | +19.17% | +23.91% | +27.31% | +52.51% | +22.39% | 58.86B | |
| -0.99% | +0.37% | -1.11% | +35.09% | +31.99% | +73.50% | -2.53% | +2.31% | -49.07% | 55.77B | |
| +0.13% | -2.75% | -11.69% | -2.25% | -22.75% | -36.50% | +12.99% | -4.32% | +180.99% | 45.14B | |
| -0.71% | -0.22% | +4.45% | +6.35% | +16.50% | +91.87% | +283.54% | +283.54% | -29.16% | 42.37B | |
| Average | -0.94% | +0.29% | +2.70% | +8.50% | +9.28% | +26.23% | +46.74% | +66.45% | +190.75% | 229.95B | |
| Weighted average by Cap. | -1.01% | +0.47% | +2.69% | +8.89% | +12.91% | +35.11% | +59.97% | +119.65% | +407.04% |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
Select your edition
All financial news and data tailored to specific country editions
